Retraction notices

Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease

Type

Retraction

Notice date

12/15/2016 0:00

Journal

Journal of Hepatology

Publisher

Elsevier

Notice DOI

10.1016/j.jhep.2016.10.020

Original paper DOI

10.1016/s0168-8278(16)01707-4

Reasons

• Concerns/Issues about Data
• Unreliable Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• Journal of Hepatology